Skip to main content
Premium Trial:

Request an Annual Quote

Hundreds of Millions More to Share

President Joe Biden has announced the US will be purchasing hundreds of millions of SARS-CoV-2 vaccine doses to donate to other countries, the Washington Post reports.

Previously, the Biden Administration said in May it would be sharing millions of SARS-CoV-2 vaccine doses with other countries and in June said it was buying 500 million doses of the Pfizer-BioNTech vaccine with plans of distributing 200 million doses this year and the rest in the first half of next year through COVAX, as the Post reported at the time. In early August, it said it was set to send 110 million SARS-CoV-2 vaccine doses abroad. Global health experts, though, told NPR at the time that billions of doses were needed.

This new announcement, timed to the UN General Assembly, doubles the number of Pfizer-BioNTech vaccine doses the US is buying to share globally, the Associated Press says, adding Biden has also embraced a goal set by aid groups to vaccinate 70 percent of the global population within a year. "To beat the pandemic here, we need to beat it everywhere," Biden said, according to the AP.

However, the AP notes that only 15 percent of promised vaccine donations from wealthy countries have been delivered and that COVAX has missed most of its sharing targets.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.